Tech Company Financing Transactions
A&G Pharmaceutical Funding Round
On 9/8/2005, A&G Pharmaceutical raised $2 million in Series A funding from New England Partners.
Transaction Overview
Company Name
Announced On
9/8/2005
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
New England Partners (Lead Investor) (Thomas Hancock)
Proceeds Purpose
The financing will be used to conduct clinical testing of the company's GP88 Biopsy Staining Kit for breast cancer, under development to help physicians determine prognosis and aid in determining the risk of breast cancer recurrence.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9130 Red Branch Rd. U
Columbia, MD 21045
USA
Columbia, MD 21045
USA
Phone
Website
Email Address
Overview
A&G Pharmaceutical is a theranostics company developing therapeutic and diagnostic products for the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ginette Serrero
VP - R & D
Jun Hayashi
Browse more venture capital transactions:
Prev: 9/8/2005: Power Paper venture capital transaction
Next: 9/9/2005: Quadriserv venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs